Goyang, South Korea

Gyeong Mo Gu

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Seegene, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gyeong Mo Gu: Innovator in Amplification Data Display Technology

Introduction

Gyeong Mo Gu is a notable inventor based in Goyang-si, South Korea. He has made significant contributions to the field of nucleic acid amplification through his innovative patent. His work focuses on enhancing the display of amplification data, which is crucial for various scientific applications.

Latest Patents

Gyeong Mo Gu holds a patent for an "Amplification data display method and device." This invention outlines a method that includes displaying a plate display area and an integrated data display area. The process involves showing plates where nucleic acid amplification reactions have been performed and presenting amplification data in the integrated data display area. The method allows for the display of multiple plates, each containing several reaction wells, thereby facilitating a comprehensive view of amplification data generated from these reactions.

Career Highlights

Gyeong Mo Gu is currently associated with Seegene, Inc., a company known for its advancements in molecular diagnostics. His role at Seegene has allowed him to further develop his expertise in amplification technologies and contribute to the company's innovative projects.

Collaborations

Gyeong Mo Gu collaborates with Kyung Hyun Min, a fellow innovator in the field. Their partnership exemplifies the collaborative spirit often found in research and development, leading to advancements in technology.

Conclusion

Gyeong Mo Gu's contributions to amplification data display technology highlight his role as an influential inventor in the scientific community. His patent and work at Seegene, Inc. demonstrate his commitment to advancing molecular diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…